• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

瑞典的默克尔细胞癌发病率正在上升。

Merkel cell carcinoma incidence is increasing in Sweden.

作者信息

Zaar O, Gillstedt M, Lindelöf B, Wennberg-Larkö A-M, Paoli J

机构信息

Department of Dermatology and Venereology, Sahlgrenska University Hospital, Institute of Clinical Sciences at the Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.

Department of Dermatology, Karolinska University Hospital, Stockholm, Sweden.

出版信息

J Eur Acad Dermatol Venereol. 2016 Oct;30(10):1708-1713. doi: 10.1111/jdv.13698. Epub 2016 May 2.

DOI:10.1111/jdv.13698
PMID:27136306
Abstract

BACKGROUND

Merkel cell carcinoma (MCC) is a rare aggressive neuroectodermal skin cancer with a high recurrence rate and a high mortality rate. Risk factors for MCC are reported to include high age, UV exposure, Caucasian skin type and immunosuppression. The incidence is reported to be increasing.

OBJECTIVE

The purpose of this study was to describe a Swedish cohort and calculate incidence.

METHODS

The study design is a retrospective cohort study of population-based data for MCC collected by the Swedish Cancer Registry to determine the incidence of MCC in Sweden and the clinical characteristics of these tumours including demographics, TNM classification, body part distribution and overall survival after diagnosis. De-identified data were collected from 1993 to 2012.

RESULTS

A total of 606 cases of MCC were identified during the study period. The median age was 81 years (range 21-99) and a majority, 54.4% were women but age-adjusted incidence is higher in men. The incidence (per 100,000) of MCC in Sweden in 1993-2012 increased from 0.09 to 0.20 for men and 0.12-0.17 for women, adjusted for age to the world standard population. For the both sexes, the increase was from 0.11 to 0.19 per 100 000, an increase of 73%. The most common site of the primary tumour was the head and neck, with 51.8% of the cases. The size of the tumour was <5 cm in 82.1% of the cases. The majority of the tumours (90.7%) had no known lymphatic spread and only a few patients had confirmed distant metastases (2.9%) when diagnosed.

CONCLUSIONS

MCC is a rare disease in Sweden, but the incidence is increasing. This study supports the finding that high age, male sex and UV exposure are risk factors for MCCs. Interventions are required to increase awareness of MCC among clinicians and the public.

摘要

背景

默克尔细胞癌(MCC)是一种罕见的侵袭性神经外胚层皮肤癌,复发率和死亡率都很高。据报道,MCC的风险因素包括高龄、紫外线暴露、白种人皮肤类型和免疫抑制。据报道,其发病率正在上升。

目的

本研究旨在描述一个瑞典队列并计算发病率。

方法

本研究设计为一项回顾性队列研究,基于瑞典癌症登记处收集的MCC人群数据,以确定瑞典MCC的发病率以及这些肿瘤的临床特征,包括人口统计学、TNM分类、身体部位分布和诊断后的总生存率。从1993年至2012年收集了去识别化的数据。

结果

在研究期间共识别出606例MCC病例。中位年龄为81岁(范围21 - 99岁),大多数(54.4%)为女性,但经年龄调整后男性的发病率更高。1993 - 2012年瑞典MCC的发病率(每10万人),经年龄调整至世界标准人群后,男性从0.09增至0.20,女性从0.12增至0.17。对于两性而言,每10万人的发病率从0.11增至0.19,增长了73%。原发性肿瘤最常见的部位是头颈部,占病例的51.8%。82.1%的病例肿瘤大小<5厘米。大多数肿瘤(90.7%)没有已知的淋巴转移,诊断时只有少数患者有确诊的远处转移(2.9%)。

结论

MCC在瑞典是一种罕见疾病,但发病率正在上升。本研究支持高龄、男性和紫外线暴露是MCC风险因素这一发现。需要采取干预措施以提高临床医生和公众对MCC的认识。

相似文献

1
Merkel cell carcinoma incidence is increasing in Sweden.瑞典的默克尔细胞癌发病率正在上升。
J Eur Acad Dermatol Venereol. 2016 Oct;30(10):1708-1713. doi: 10.1111/jdv.13698. Epub 2016 May 2.
2
Incidence and survival for Merkel cell carcinoma in Queensland, Australia, 1993-2010.澳大利亚昆士兰州 1993-2010 年 Merkel 细胞癌的发病率和生存率。
JAMA Dermatol. 2014 Aug;150(8):864-72. doi: 10.1001/jamadermatol.2014.124.
3
Merkel cell carcinoma - a population-based epidemiological study in Finland with a clinical series of 181 cases.默克尔细胞癌——芬兰一项基于人群的流行病学研究,附 181 例临床病例系列
Eur J Cancer. 2012 Mar;48(5):737-42. doi: 10.1016/j.ejca.2011.06.001. Epub 2011 Jul 4.
4
Merkel cell carcinoma: incidence, mortality, and risk of other cancers. Merkel 细胞癌:发病率、死亡率和其他癌症风险。
J Natl Cancer Inst. 2010 Jun 2;102(11):793-801. doi: 10.1093/jnci/djq120. Epub 2010 Apr 27.
5
Second cancers following the diagnosis of Merkel cell carcinoma: a nationwide cohort study.诊断 Merkel 细胞癌后的第二癌症:一项全国性队列研究。
Cancer Epidemiol. 2010 Feb;34(1):62-5. doi: 10.1016/j.canep.2009.12.007. Epub 2010 Jan 12.
6
Merkel cell carcinoma in Western Australia: a population-based study of incidence and survival.西澳大利亚的 Merkel 细胞癌:基于人群的发病率和生存率研究。
Br J Dermatol. 2011 Nov;165(5):1051-7. doi: 10.1111/j.1365-2133.2011.10493.x. Epub 2011 Sep 29.
7
Epidemiology of Merkel cell carcinoma. A population-based study from 1985 to 2013, in northeastern of France.默克尔细胞癌的流行病学。1985 年至 2013 年法国东北部的一项基于人群的研究。
Int J Cancer. 2019 Feb 15;144(4):741-745. doi: 10.1002/ijc.31860. Epub 2018 Oct 4.
8
Incidence of Merkel cell carcinoma in Olmsted County, Minnesota: a population-based study.明尼苏达州奥尔姆斯特德县默克尔细胞癌的发病率:一项基于人群的研究。
Int J Dermatol. 2016 Jan;55(1):e11-5. doi: 10.1111/ijd.12812. Epub 2015 Jul 31.
9
Merkel cell carcinoma of the eyelid: management and prognosis.眼睑 Merkel 细胞癌:治疗和预后。
JAMA Ophthalmol. 2014 Feb;132(2):197-204. doi: 10.1001/jamaophthalmol.2013.6077.
10
Treatment and survival of Merkel cell carcinoma since 1993: A population-based cohort study in The Netherlands.自 1993 年以来 Merkel 细胞癌的治疗和生存情况:荷兰的一项基于人群的队列研究。
J Am Acad Dermatol. 2019 Oct;81(4):977-983. doi: 10.1016/j.jaad.2019.01.042. Epub 2019 Jan 29.

引用本文的文献

1
Incidence and outcomes of Merkel cell carcinoma related to Merkel cell polyomavirus status in Iceland in 1981-2023.1981年至2023年冰岛默克尔细胞多瘤病毒状态相关默克尔细胞癌的发病率及转归
JAAD Int. 2024 Jul 14;17:192-199. doi: 10.1016/j.jdin.2024.06.004. eCollection 2024 Dec.
2
Zinc oxide nanoparticles derived from Penicillium griseofulvum mitigate DMBA/TPA-promoted mice skin carcinogenesis by modulating NF-ĸB associated signalling.源自灰黄青霉的氧化锌纳米颗粒通过调节NF-κB相关信号通路减轻DMBA/TPA诱导的小鼠皮肤癌发生。
Naunyn Schmiedebergs Arch Pharmacol. 2025 Jan;398(1):891-902. doi: 10.1007/s00210-024-03311-4. Epub 2024 Jul 30.
3
Dermoscopic characteristics of Merkel cell carcinoma.
Merkel 细胞癌的皮肤镜特征。
BMC Cancer. 2024 Jul 1;24(1):785. doi: 10.1186/s12885-024-12566-2.
4
Incidence of Non-Melanoma Skin Cancers in Salento (Southern Italy): A 15-Year Retrospective Analysis from the Cancer Registry of Lecce.萨伦托(意大利南部)非黑色素瘤皮肤癌的发病率:来自莱切癌症登记处的15年回顾性分析
Epidemiologia (Basel). 2023 Dec 21;5(1):1-10. doi: 10.3390/epidemiologia5010001.
5
High-volume facilities are significantly more likely to use guideline-adherent systemic immunotherapy for metastatic Merkel cell carcinoma: implications for cancer care regionalization.大容量设施更有可能对转移性 Merkel 细胞癌使用符合指南的全身性免疫疗法:对癌症治疗区域化的影响。
Arch Dermatol Res. 2024 Feb 13;316(3):86. doi: 10.1007/s00403-024-02817-4.
6
Imaging of Merkel cell carcinoma of the eyelid: A case report.眼睑默克尔细胞癌的影像学表现:一例报告
Oncol Lett. 2024 Jan 23;27(3):119. doi: 10.3892/ol.2024.14252. eCollection 2024 Mar.
7
Color Analysis of Merkel Cell Carcinoma: A Comparative Study with Cherry Angiomas, Hemangiomas, Basal Cell Carcinomas, and Squamous Cell Carcinomas.默克尔细胞癌的颜色分析:与樱桃状血管瘤、血管瘤、基底细胞癌和鳞状细胞癌的对比研究
Diagnostics (Basel). 2024 Jan 22;14(2):230. doi: 10.3390/diagnostics14020230.
8
Critical involvement of circular RNAs in virus-associated cancers.环状RNA在病毒相关癌症中的关键作用。
Genes Dis. 2022 May 7;10(6):2296-2305. doi: 10.1016/j.gendis.2022.04.009. eCollection 2023 Nov.
9
An Effective Primary Treatment Using Radiotherapy in Patients with Eyelid Merkel Cell Carcinoma.眼瞼 Merkel 細胞癌患者的放射治療有效初步治療。
Curr Oncol. 2023 Jul 2;30(7):6353-6361. doi: 10.3390/curroncol30070468.
10
Case report: Metastatic Merkel cell carcinoma presenting seven years after loco-regional disease resection of primary tumor with interval in-transit and nodal metastases.病例报告:原发性肿瘤局部区域疾病切除术后七年出现转移性默克尔细胞癌,期间伴有皮下转移和淋巴结转移。
Front Oncol. 2023 Jul 5;13:1217816. doi: 10.3389/fonc.2023.1217816. eCollection 2023.